XBiotech Inc. (XBIT) Financial Analysis & Valuation | Quarter Chart
XBiotech Inc. (XBIT)
XBITPrice: $2.31
Fair Value: 🔒
🔒score
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleuki... more
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoc... more
Description
Shares
| Market Cap | $70.43M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | US | CEO | Sushma Shivaswamy |
| IPO Date | 2015-04-15 | CAGR | — |
| Employees | 92 | Website | www.xbiotech.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
XBIT chart loading...
Fundamentals
Technicals
| Enterprise Value | $-47.78M | P/E Ratio | -1.78 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | 0.34 |
| P/CF Ratio | -1.06 | P/FCF Ratio | -1.06 |
| EPS | $-1.3 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | — | Gross Margin | — |
| Operating Margin | — | Profit Margin | — |
| ROE | -0.26% | ROA | -0.29% |
| ROCE | -0.35% | Current Ratio | 39.03 |
| Quick Ratio | 39.03 | Cash Ratio | 38.5 |
| Debt/Equity | — | Interest Coverage | — |
| Altman Z Score | 7.44 | Piotroski Score | 1 |